Impact of Standing Orders Optimization (NCT05742386) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Impact of Standing Orders Optimization
United States27 participantsStarted 2023-02-22
Plain-language summary
This trial will look at the impact of optimizing human papillomavirus (HPV) vaccine standing orders. The research team will work with primary care clinics. Some clinics will receive communication training. Other clinics will receive the same training and tools for increasing the use of their standing orders.
Who can participate
Age range
9 Years – 12 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
This trial will enroll clinics and intervene with clinical staff. We will use vaccination data from children and survey data from clinical staff to evaluate intervention effectiveness. We will not enroll children or interact with them directly.
Inclusion Criteria
Clinics are eligible if they:
* provide HPV vaccine to children ages 9-12
* have standing orders for HPV vaccination approved but not routinely used or be willing to adopt them prior to the start of the trial
* have rates of HPV vaccination (≥1 dose) below 72%, boys and girls combined
Children's medical records will be eligible to be included in the dataset if children:
* are between the ages of 9-12 years at baseline
* are attributed to a participating clinic at 12- or 24-month follow-up
Clinical staff's survey data will be eligible to be included in the dataset if clinical staff complete the follow-up survey.
Exclusion Criteria
Clinics are excluded if they:
* do not provide HPV vaccine to children ages 9-12
* do not have standing orders for HPV vaccination or are not willing to adopt them prior to the start of the trial
* have rates of HPV vaccination (≥1 dose) above 72%, boys and girls combined
* have hosted an AAT workshop in the previous 3 years or are part of current HPV vaccine communication trainings
* have quality improvement efforts to change HPV vaccine standing orders during the trial
Children's medical records will not be eligible to be included in the dataset if children:
* are not between th…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.